Frequently Asked Questions
The market is segmented based on , By Product (Reagents, Instruments, and Software and Services), Technology (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test and Others), Application (Infectious Diseases, Oncology and Endocrinology, Hepatitis and Retrovirus, Bone and Mineral, Autoimmunity, Cardiac Biomarker and Others), End User (Clinical Laboratories, Hospitals, Academic and Research Centers, Pharmaceutical and Biotechnology Industry, Others) - Industry Trends and Forecast to 2030.
.
The Global Immunodiagnostics Market size was valued at USD 16.87 USD Billion in 2022.
The Global Immunodiagnostics Market is projected to grow at a CAGR of 12.8% during the forecast period of 2023 to 2030.
The major players operating in the market include Omega Diagnostics Group PLC, Nexus Dx, Protagen Protein Services GmbH, Quest Diagnostics orporated, Seramun Diagnostica GmbH, SQI Diagnostics, Tecan Trading AG, Siemens, DiaSorin S.p.A., Erba Diagnostics, Svar Life Science AB, Exagen , Abbott, F. Hoffmann La Roche Ltd, Danaher, Adaptive Biotechnologies, QIAGEN, AMARANTUS BIOSCIENCE HOLDINGS, AESKU.GROUP GmbH, Avant Diagnostics, .
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa).
